RxDoctor Payments Data

Nathalie Spencer Sweeney, APRN

Family · Ashland, KYNPI 1437701141

Payments from drug & device makers

$4,787in general payments, 2019–2025

Across 356 payments — averaging $13.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
  • Pfizer$592
  • Merck$319
  • Boehringer Ingelheim$303
  • E.r. Squibb & Sons, L.L.C.$167
  • plus $578 from 13 others

What the payments were for

  • Food & beverage$4,787100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,787 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,718
Medicare patients
36
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban257$256,274
XareltoRivaroxaban93$85,224
EntrestoSacubitril/Valsartan75$81,074
JardianceEmpagliflozin45$43,760
FarxigaDapagliflozin Propanediol15$18,025
Repatha SureclickEvolocumab11$8,287
Ranolazine ErRanolazine70$7,739
Prasugrel Hcl30$7,066
Metoprolol Succinate302$3,144
Diltiazem 24hr Er (Cd)Diltiazem Hcl88$3,059
Flecainide Acetate53$2,933
Potassium Chloride101$2,686
Atorvastatin Calcium377$2,411
SotalolSotalol Hcl64$1,908
Rosuvastatin Calcium138$1,661

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$592$256,274257 claims
Johnson & JohnsonXarelto$16$85,22493 claims
NovartisEntresto$1,584$81,07475 claims
Boehringer IngelheimJardiance$303$43,76045 claims
AstraZenecaFarxiga$111$18,02515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →